1. Home
  2. ITRM vs KLXE Comparison

ITRM vs KLXE Comparison

Compare ITRM & KLXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRM
  • KLXE
  • Stock Information
  • Founded
  • ITRM 2015
  • KLXE 2018
  • Country
  • ITRM Ireland
  • KLXE United States
  • Employees
  • ITRM N/A
  • KLXE N/A
  • Industry
  • ITRM Biotechnology: Pharmaceutical Preparations
  • KLXE Oilfield Services/Equipment
  • Sector
  • ITRM Health Care
  • KLXE Energy
  • Exchange
  • ITRM Nasdaq
  • KLXE Nasdaq
  • Market Cap
  • ITRM 40.0M
  • KLXE 35.8M
  • IPO Year
  • ITRM 2018
  • KLXE N/A
  • Fundamental
  • Price
  • ITRM $0.82
  • KLXE $1.87
  • Analyst Decision
  • ITRM Strong Buy
  • KLXE Hold
  • Analyst Count
  • ITRM 2
  • KLXE 1
  • Target Price
  • ITRM $7.00
  • KLXE $4.50
  • AVG Volume (30 Days)
  • ITRM 751.2K
  • KLXE 179.6K
  • Earning Date
  • ITRM 08-13-2025
  • KLXE 08-06-2025
  • Dividend Yield
  • ITRM N/A
  • KLXE N/A
  • EPS Growth
  • ITRM N/A
  • KLXE N/A
  • EPS
  • ITRM N/A
  • KLXE N/A
  • Revenue
  • ITRM N/A
  • KLXE $688,600,000.00
  • Revenue This Year
  • ITRM N/A
  • KLXE N/A
  • Revenue Next Year
  • ITRM $270.19
  • KLXE $3.97
  • P/E Ratio
  • ITRM N/A
  • KLXE N/A
  • Revenue Growth
  • ITRM N/A
  • KLXE N/A
  • 52 Week Low
  • ITRM $0.81
  • KLXE $1.46
  • 52 Week High
  • ITRM $3.02
  • KLXE $7.66
  • Technical
  • Relative Strength Index (RSI)
  • ITRM 35.21
  • KLXE 47.47
  • Support Level
  • ITRM $0.81
  • KLXE $1.69
  • Resistance Level
  • ITRM $0.90
  • KLXE $2.08
  • Average True Range (ATR)
  • ITRM 0.08
  • KLXE 0.16
  • MACD
  • ITRM -0.02
  • KLXE 0.02
  • Stochastic Oscillator
  • ITRM 4.46
  • KLXE 70.16

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

Share on Social Networks: